In October 2024, Novartis announced that based on its review of 48-week data from the Phase 3 MANIFEST-2 study, longer follow-up time is needed to determine the regulatory path for pelabresib in ...

Mattel continues to harvest gains from its turnaround, delivering above breakeven operating margins starting in 2019 and reaching 13.7% in 2024. Despite the outlook for modestly positive sales growth, ...

On February 6, 2025, the SEC announced that it was providing a temporary exemption from compliance with Rule 13f-2 under the ...

InMode benefits from the booming non-invasive plastic surgery market, expected to grow at a 14% CAGR from 2023 to 2030. Read ...

Proto Labs, Inc. ("Protolabs" or the "Company") (NYSE: PRLB), the world's leading provider of digital manufacturing services, today announced financial results for the ...

Varex Imaging Corporation (Nasdaq: VREX) today announced its unaudited financial results for the first quarter of fiscal year 2025. 1QFY25 Summary Revenues ...

Net sales from our most important Hong Kong business up sequentially and year-over-year during the 4th quarter– Positive cash flows from ...

The Bancorp, Inc. ("The Bancorp" or the "Company" or "we" or "our") (NASDAQ: TBBK), a financial holding company, today reported its financial results for the fourth quarter and full year of 2024.

"Strong enterprise sales execution drove better-than-expected ... share of $0.33 for the second quarter of fiscal year 2024.

The Company Generates Record Annual Revenue of $522.3 Million, 6th Consecutive Quarter of Positive Free Cash Flow at $5.9 ...

Includes charges related to restructuring and severance, as well as various transformation initiative costs, primarily consisting of supply chain transformation costs and changes to our business ...

Sysco Corporation (NYSE: SYY) (“Sysco” or the “company”) today announced financial results for its 13-week second fiscal quarter ended December 28, 2024. Key financial results for the second quarter ...